People: Henry Schein Inc (HSIC.OQ)

HSIC.OQ on NASDAQ Stock Exchange Global Select Market

138.07USD
30 Jan 2015
Change (% chg)

$-1.94 (-1.39%)
Prev Close
$140.01
Open
$139.47
Day's High
$139.94
Day's Low
$137.82
Volume
215,272
Avg. Vol
203,817
52-wk High
$143.89
52-wk Low
$109.34

Search Stocks

Sheares, Bradley 

Brief Biography

Dr. Bradley T. Sheares, Ph.D., is an Independent Director of Henry Schein, Inc., since January 2010. Dr. Sheares served as Chief Executive Officer of Reliant Pharmaceuticals, Inc., from 2007 through its acquisition by GlaxoSmithKline plc in 2007. Prior to joining Reliant, Dr. Sheares served as President of U.S. Human Health for Merck & Co. from 2001 until 2006. As a member of Merck’s management committee, Dr. Sheares had responsibility for formulating global business strategies, operations management and the development and implementation of corporate policies. He is also a director of Honeywell International (and is a member of its management development and compensation committee and retirement plan committee) and is a director and Chairman of the compensation committees at both The Progressive Corporation and Covance Inc. As a director of numerous other public companies, Dr. Sheares has been involved in succession planning, compensation, employee management and the evaluation of acquisition opportunities. During the past five years, Dr. Sheares served on the Board of Directors of IMS Health Incorporated.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stanley Bergman

6,212,960

James Breslawski

2,270,570

Steven Paladino

2,029,460

David McKinley

--

Bob Minowitz

--

Lonnie Shoff

--
As Of 27 Dec 2013
Search Stocks